Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S-1 plus cisplatin HIPEC in stage IV gastric cancer
NCT02291211Phase 2Unknown
- Sponsor
- Tangdu Hospital
- Start
- Sep 2014
- Primary completion
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tegafur, cisplatin in gastric cancer (GC), sponsored by Tangdu Hospital. Status: unknown.
02
Drugs
tegafurcisplatin
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT02291211.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02291211.